Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -356.81% is 96% below its 5-year average of -181.98%, around the middle of its 5-year range (-981.31%–77.85%).
As of the fiscal period ended Tuesday, March 31, 2026. 16.20% above its 12-month average of -425.77%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
-356.81%
OPERATING MARGIN AVG TTM
-425.77%
OPERATING MARGIN AVG 3Y
-331.55%
OPERATING MARGIN AVG 5Y
-142.02%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+16.20%
CURRENT VS 3Y AVG
-7.62%
CURRENT VS 5Y AVG
-151.25%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.61%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-2385.79%
vs the sector median at left
Moderna, Inc.
Market Cap
$21.45B
Operating Margin
-356.81%
TTM Avg
-425.77%
3Y Avg
-331.55%
5Y Avg
-142.02%
Market Cap
$22.43B
Operating Margin
45.34%
TTM Avg
47.77%
3Y Avg
49.26%
5Y Avg
45.01%
Market Cap
$20.08B
Operating Margin
-18.62%
TTM Avg
-9.28%
3Y Avg
-0.91%
5Y Avg
-0.93%
Market Cap
$23.10B
Operating Margin
20.64%
TTM Avg
20.32%
3Y Avg
22.80%
5Y Avg
22.92%
Market Cap
$23.51B
Operating Margin
27.05%
TTM Avg
14.26%
3Y Avg
15.92%
5Y Avg
12.23%
Market Cap
$24.34B
Operating Margin
11.03%
TTM Avg
9.61%
3Y Avg
9.32%
5Y Avg
13.00%
Market Cap
$24.42B
Operating Margin
28.22%
TTM Avg
28.07%
3Y Avg
28.30%
5Y Avg
28.33%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | $21.45B | -356.81% | -425.77% | -331.55% | -142.02% |
| STERIS plc (STE)vs › | $20.86B | 18.56% | 17.21% | 17.04% | 16.18% |
| United Therapeutics Corporation (UTHR)vs › | $22.43B | 45.34% | 47.77% | 49.26% | 45.01% |
| BioNTech SE (BNTX)vs › | $22.59B | -22.63% | -35.20% | 5.18% | 14.03% |
| Viatris Inc. (VTRS)vs › | $20.08B | -18.62% | -9.28% | -0.91% | -0.93% |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.10B | 20.64% | 20.32% | 22.80% | 22.92% |
| Incyte Corporation (INCY)vs › | $23.51B | 27.05% | 14.26% | 15.92% | 12.23% |
| Labcorp Holdings Inc. (LH)vs › | $24.34B | 11.03% | 9.61% | 9.32% | 13.00% |
| Waters Corporation (WAT)vs › | $24.42B | 28.22% | 28.07% | 28.30% | 28.33% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.15B | 14.14% | 14.08% | 14.06% | 16.54% |
Gross Margin
55.4%
Operating Margin
-356.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | -356.81% |
| 2025-12-31 | -126.40% |
| 2025-09-30 | -25.59% |
| 2025-06-30 | -638.73% |
| 2025-03-31 | -981.31% |
| 2024-12-31 | -130.33% |
| 2024-09-30 | -3.77% |
| 2024-06-30 | -616.74% |
| 2024-03-31 | -758.08% |
| 2023-12-31 | 0.21% |
| 2023-09-30 | -109.89% |
| 2023-06-30 | -542.73% |
| 2023-03-31 | -19.91% |
| 2022-12-31 | 30.69% |
| 2022-09-30 | 36.21% |
| 2022-06-30 | 53.59% |
| 2022-03-31 | 71.16% |
| 2021-12-31 | 77.85% |
| 2021-09-30 | 73.68% |
| 2021-06-30 | 72.65% |
| 2021-03-31 | 72.63% |
| 2020-12-31 | -48.19% |
| 2020-09-30 | -148.89% |
| 2020-06-30 | -184.06% |
| 2020-03-31 | -1559.92% |
| 2019-12-31 | -928.89% |
| 2019-09-30 | -767.12% |
| 2019-06-30 | -1098.44% |
| 2019-03-31 | -883.88% |
| 2018-12-31 | -432.03% |
| 2018-09-30 | -205.52% |
| 2018-06-30 | -336.26% |
| 2018-03-31 | -266.54% |
| 2017-12-31 | -45.51% |
| 2017-09-30 | -159.80% |
| 2017-06-30 | -223.46% |
| 2017-03-31 | -223.46% |
